Perspective Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Perspective Therapeutics, Inc. (CATX) is 171.97M

According to Perspective Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 171.97M. This represents a change of 18.72% compared to the average of 144.85M of the last 4 quarters.

Perspective Therapeutics, Inc. (CATX) Historical Enterprise Value (quarterly & annually)

How has CATX Enterprise Value performed in the past?

The mean historical Enterprise Value of Perspective Therapeutics, Inc. over the last ten years is 241.98M. The current 171.97M Enterprise Value has changed 7.01% with respect to the historical average. Over the past ten years (40 quarters), CATX's Enterprise Value was at its highest in in the September 2024 quarter at 720.72M. The Enterprise Value was at its lowest in in the March 2026 quarter at -45420713.20.

Perspective Therapeutics, Inc. (CATX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Perspective Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Perspective Therapeutics, Inc. (CATX) Average Enterprise Value

How has CATX Enterprise Value performed in the past?

The current Enterprise Value of Perspective Therapeutics, Inc. (CATX) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Perspective Therapeutics, Inc. (CATX) Enterprise Value vs. Peers

How is CATX’s Enterprise Value compared to its peers?

Perspective Therapeutics, Inc.’s Enterprise Value is less than Profound Medical Corp. (221.97M), greater than TriSalus Life Sciences, Inc. (143.98M), greater than Nyxoah S.A. (71.29M), greater than Solana Company (91.94M), greater than Invivyd, Inc. (-15555399.00), greater than MaxCyte, Inc. (111.12M), greater than Nano-X Imaging Ltd. (24.84M), greater than Anteris Technologies Global Corp. (11.15M), less than Electromed, Inc. (315.62M), less than Neuronetics, Inc. (198.82M),

Build a custom stock screener for Perspective Therapeutics, Inc. (CATX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perspective Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Perspective Therapeutics, Inc. (CATX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Perspective Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.